Menu
PacPremier
Magic Hour
Montecito
SoCal Gas
Loading...
You are here:  Home  >  'Allergan'  -  Page 3
Latest

Dubroff: Allergan all about stripping out assets and avoiding taxes

By   /  Friday, April 8th, 2016  /  Columns, Latest news  /  Comments Off on Dubroff: Allergan all about stripping out assets and avoiding taxes

Henry Dubroff

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Kythera laying off 117 employees in Westlake Village

By   /  Tuesday, October 13th, 2015  /  Central Coast Health Watch, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Kythera laying off 117 employees in Westlake Village

Kythera Biopharmaceuticals is permanently laying off 117 employees at its Westlake Village offices, according to a filing today with the Securities and Exchange Commission. The layoffs come as no surprise and appear to be part of Kythera’s merger with Dublin-based Allergan. On June 17, Allergan announced that it would buy Kythera for $2.1 billion. The Read More →

Read More →
Latest

Study shows Amgen’s new biosimilar cancer drug safe, effective

By   /  Wednesday, September 23rd, 2015  /  Latest news, Technology, Top Stories  /  Comments Off on Study shows Amgen’s new biosimilar cancer drug safe, effective

Pharmaceuticals Amgen and Allergan announced positive Phase 3 study results of their new drug ABP 215 on Sept. 23. The drug, used to treat lung cancer, is being developed as a biosimilar to Roche Holding AG’s Avastin. ABP 215 showed clinical safety and effectiveness compared to Avastin. “Lung cancer is the leading cause of cancer Read More →

Read More →
Latest

Dubroff: Washington dysfunction over taxes could cost jobs in Tri-Counties

By   /  Friday, August 7th, 2015  /  Central Coast Health Watch, Columns, Tri-County Economy  /  Comments Off on Dubroff: Washington dysfunction over taxes could cost jobs in Tri-Counties

This is a column about how dysfunction in Washington is handing billions over to Wall Street while threatening thousands of jobs on the Central Coast. Just a year ago, Allergan shut its Goleta breast implant operation after it came under siege from corporate raiders, Activis, a New Jersey-based company that used an acquisition in Ireland Read More →

Read More →
Latest

Allergan buys Westlake Village-based Kythera for $2.1 billion

By   /  Friday, June 19th, 2015  /  Central Coast Health Watch, East Ventura County, Latest news, Technology, Top Stories, Tri-County Economy, Tri-County Public Companies  /  Comments Off on Allergan buys Westlake Village-based Kythera for $2.1 billion

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.

Read More →
Latest

Allergan buying Westlake Village-based Kythera Biopharmaceuticals Inc.

By   /  Wednesday, June 17th, 2015  /  East Ventura County, Latest news, Top Stories, Tri-County Public Companies  /  Comments Off on Allergan buying Westlake Village-based Kythera Biopharmaceuticals Inc.

Just a few months after it shut a Santa Barbara facility, Botox-maker Allergan has re-entered the Tri-Counties, agreeing to buy Kythera Biopharmaceuticals Inc. for about $2.1 billion. The deal will add the Westlake Village-based Kythera’s treatments for double chins and male pattern baldness to Allergan’s existing line of products, including a breast implant operation formerly Read More →

Read More →
Latest

Allergan alumni launch FDA compliance firm

By   /  Friday, December 12th, 2014  /  Latest news, South Coast, Technology, Top Stories  /  Comments Off on Allergan alumni launch FDA compliance firm

Though the services provided by 123Compliance may not deliver the behemoth employer that could replace Allergan’s big footprint, the company, with 20 employees worldwide, has been growing exponentially.

Read More →